Nephros, Inc. NEPH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.62M | 6.02M | 5.21M | 4.73M | 4.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.62M | 6.02M | 5.21M | 4.73M | 4.76M |
| Cost of Revenue | 2.34M | 1.99M | 2.22M | 1.97M | 1.85M |
| Gross Profit | 3.29M | 4.03M | 2.99M | 2.76M | 2.92M |
| SG&A Expenses | 2.43M | 2.42M | 2.52M | 2.32M | 2.23M |
| Depreciation & Amortization | 29.00K | 29.00K | 29.00K | 32.00K | 34.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.12M | 4.80M | 5.12M | 4.71M | 4.45M |
| Operating Income | 501.00K | 1.21M | 97.00K | 18.00K | 314.00K |
| Income Before Tax | 512.00K | 1.21M | 140.00K | 62.00K | 340.00K |
| Income Tax Expenses | -- | 13.00K | -- | 0.00 | 3.00K |
| Earnings from Continuing Operations | 512.00K | 1.20M | 140.00K | 62.00K | 337.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 512.00K | 1.20M | 140.00K | 62.00K | 337.00K |
| EBIT | 501.00K | 1.21M | 97.00K | 18.00K | 314.00K |
| EBITDA | 530.00K | 1.24M | 124.00K | 55.00K | 346.00K |
| EPS Basic | 0.05 | 0.11 | 0.01 | 0.01 | 0.03 |
| Normalized Basic EPS | 0.03 | 0.07 | 0.01 | 0.00 | 0.02 |
| EPS Diluted | 0.05 | 0.11 | 0.01 | 0.01 | 0.03 |
| Normalized Diluted EPS | 0.03 | 0.07 | 0.01 | 0.00 | 0.02 |
| Average Basic Shares Outstanding | 10.86M | 10.86M | 10.65M | 10.65M | 10.61M |
| Average Diluted Shares Outstanding | 11.20M | 11.11M | 10.99M | 11.21M | 11.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |